Profound Medical Sets Aug. 6 Date for Q2 2026 Results, Call at 4:30 p.m. ET
Toronto – October 12, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) will report its second quarter 2026 financial results after market close on Thursday, August 6, 2026.
Management hosts call at 4:30 p.m. ET on results day
The interventional MRI (iMRI) company will hold a conference call at 4:30 p.m. ET on August 6 to review the quarter's results and discuss business developments in the period. Investors must register in advance for the live call.
Two MRI-guided platforms drive the commercial portfolio
Profound markets TULSA-PRO, which is FDA-cleared in the United States for transurethral ultrasound ablation (TULSA) of prostate tissue. The system is also cleared in Europe, Canada, Saudi Arabia, India, Australia/New Zealand and the UAE.